236 related articles for article (PubMed ID: 38706602)
1. Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC.
Kumar SS; Fathima A; Srihari P; Jamma T
Front Oncol; 2024; 14():1392565. PubMed ID: 38706602
[TBL] [Abstract][Full Text] [Related]
2. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
3. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
Salminen A
J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
[TBL] [Abstract][Full Text] [Related]
4. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.
Cai J; Sun L; Gonzalez FJ
Cell Host Microbe; 2022 Mar; 30(3):289-300. PubMed ID: 35271802
[TBL] [Abstract][Full Text] [Related]
7. Microbial Metabolite Dysbiosis and Colorectal Cancer.
Niekamp P; Kim CH
Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
[TBL] [Abstract][Full Text] [Related]
8. Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway.
Yi S; Jin X; Liu B; Wu P; Xiao W; Chen W
Phytomedicine; 2022 Oct; 105():154279. PubMed ID: 35963192
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
Front Immunol; 2022; 13():974305. PubMed ID: 36211363
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.
Liu A; Liang X; Wang W; Wang C; Song J; Guo J; Sun D; Wang D; Song M; Qian J; Zhang X
Stem Cell Res Ther; 2023 Sep; 14(1):271. PubMed ID: 37749611
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.
Dong S; Zhu M; Wang K; Zhao X; Hu L; Jing W; Lu H; Wang S
Pharmacol Res; 2021 Sep; 171():105767. PubMed ID: 34273490
[TBL] [Abstract][Full Text] [Related]
13. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
[TBL] [Abstract][Full Text] [Related]
14. Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation.
Li C; Liang Y; Qiao Y
Front Microbiol; 2022; 13():863407. PubMed ID: 35531300
[TBL] [Abstract][Full Text] [Related]
15. The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.
Sun C; Zhu D; Zhu Q; He Z; Lou Y; Chen D
Front Cell Infect Microbiol; 2024; 14():1337223. PubMed ID: 38404291
[TBL] [Abstract][Full Text] [Related]
16. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Immune System Interactions.
Yoo JY; Groer M; Dutra SVO; Sarkar A; McSkimming DI
Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33076307
[TBL] [Abstract][Full Text] [Related]
18. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
19. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
20. A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.
Xu F; Yu Z; Liu Y; Du T; Yu L; Tian F; Chen W; Zhai Q
Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
